Efficacy of Arthrocentesis by Injection of Ringer With or Without Corticosteroid in Treatment of Internal Derangement
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01958879 |
Recruitment Status :
Completed
First Posted : October 9, 2013
Last Update Posted : October 7, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Temporomandibular Joint Dysfunction Pain Arthrocentesis | Drug: ringer with corticosteroid Drug: ringer without corticosteroid | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Treatment of Temporomandibular Disorder |
Study Start Date : | September 2012 |
Actual Primary Completion Date : | October 2013 |
Actual Study Completion Date : | November 2013 |
Arm | Intervention/treatment |
---|---|
Experimental: ringer with corticosteroid
Intra-articular irrigation was performed under local anesthesia with subcutaneous injection of 1%lidocaine solution (0.6 to 0.9 mL anaesthetic solution )was injected to block the auriculotemporal nerve. Then the skin on the TMJ was penetrated with a 21-gauge needle at the articular fossa followed by the injection of 3 mL Ringer solution to distend the joint space, pumping it in and out repeatedly. Another 21-gauge needle was inserted into the distended compartment in the area of the articular eminence, and the superior joint space was irrigated with 200 mL Ringer solution, allowing a free flow through the first needle in the both groups .In this group patients received 1mg dexamethasone after finishing the irrigation .
|
Drug: ringer with corticosteroid
200 mL Ringer solution+1mg dexamethasone after finishing the irrigation |
Placebo Comparator: Ringer with out corticosteroid
Intra-articular irrigation was performed under local anesthesia with subcutaneous injection of 1%lidocaine solution (0.6 to 0.9 mL anaesthetic solution )was injected to block the auriculotemporal nerve. Then the skin on the TMJ was penetrated with a 21-gauge needle at the articular fossa followed by the injection of 3 mL Ringer solution to distend the joint space, pumping it in and out repeatedly. Another 21-gauge needle was inserted into the distended compartment in the area of the articular eminence, and the superior joint space was irrigated with 200 mL Ringer solution, allowing a free flow through the first needle in the both groups
|
Drug: ringer without corticosteroid
200 mL Ringer solution |
- pain [ Time Frame: 6 months ]Pain will be assessed preoperatively and again at 1 and 6 months using a visual analogue scale
- function [ Time Frame: 6 months ]Mouth opening was measured as the maximum interincisal distance in millimeters using a scale
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 15 Years to 80 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with clinical findings characteristic of internal derangement(clicking and joint pain lasting for more than 6 months) unilaterally or bilaterally and history of previous conservative drug therapy (NSAIDs and Muscle relaxant ),splint therapy and physiotherapy without improvement.
- Patients of both sexes between 15 to 80 year's old
- Patients who are willing for evaluation in 1 and 6 months after arthrocentesis
- Patients who are provided written consent form
Exclusion Criteria:
- Patient had systemic problems which affect bone and joints disease
- Patient with psychological problems
- Patient with history of maxillofacial fractures and orthognathic
- Patients who can not continue the study for private or social reasons
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01958879
Iran, Islamic Republic of | |
Shiraz university of medical sciences | |
Shiraz, Iran, Islamic Republic of |
Study Chair: | Reza Tabrizi, DMD | SUMS | |
Study Director: | Reza Tabrizi, DMD | SUMS | |
Principal Investigator: | Touba Karagah, DMD | SUMS |
Responsible Party: | Reza Tabrizi, OMFS, Shiraz University of Medical Sciences |
ClinicalTrials.gov Identifier: | NCT01958879 |
Other Study ID Numbers: |
12345 |
First Posted: | October 9, 2013 Key Record Dates |
Last Update Posted: | October 7, 2014 |
Last Verified: | October 2013 |
internal derangement,arthrocentesis,corticosteroid |
Joint Diseases Temporomandibular Joint Disorders Temporomandibular Joint Dysfunction Syndrome Musculoskeletal Diseases Craniomandibular Disorders |
Mandibular Diseases Jaw Diseases Muscular Diseases Stomatognathic Diseases Myofascial Pain Syndromes |